Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
21.02. | Fast-growing chip connectivity firm Astera Labs files for an estimated $500 million IPO | ||
20.02. | Early-stage mining company Key Mining increases deal size by 61% ahead of $16 million IPO | ||
20.02. | Singapore-based tech firm Orangekloud Technology files and sets terms for a $14 million US IPO | ||
17.02. | US IPO Week Ahead: IPO calendar sees a handful of small holdovers as seasonal lull continues | ||
17.02. | US IPO Weekly Recap: Nano-caps debut in quiet week | ||
16.02. | Hong Kong-based mF International lowers deal size by 5%, changes lead bank ahead of $8 million US IPO | ||
16.02. | Pain relief biotech Chromocell Therapeutics prices IPO at $6 midpoint | ||
15.02. | Chinese recruiting services provider Lucas GC lowers deal size by 69% ahead of $6 million US IPO | ||
15.02. | Surgical robotics company SS Innovations International files for a $50 million Nasdaq uplisting | ||
15.02. | Cancer biotech Kairos Pharma sets terms for $6 million IPO | ||
14.02. | Drone tech developer Unusual Machines prices IPO at $4, the low end of the range | ||
14.02. | Hemp-based smokables retailer Maverick Lifestyle sets terms for $4 million IPO | ||
14.02. | Renaissance IPO Index's longest winning streak of 2024 to date cut short by inflation data | ||
13.02. | Touchscreen maker Wetouch Technology lowers share offering by 25% ahead of $18 million Nasdaq uplisting | ||
13.02. | Media content hub TPT Global Tech files for a $50 million Nasdaq uplisting | ||
12.02. | BZX Exchange emerges as a new option for small listings as US IPO market heats up | ||
10.02. | US IPO Week Ahead: Medley of small listings set to come to the IPO market | ||
10.02. | US IPO Weekly Recap: Autoimmune biotech Kyverna Therapeutics gains 37% in a 6 IPO week | ||
10.02. | Biomanufacturing company Invizyne Technologies files and sets terms for a $17 million IPO | ||
10.02. | Blockchain-based platform developer TessPay sets terms for $7 million IPO | ||
09.02. | Not the usual suspects: the geographies producing some of 2024's largest global IPOs | ||
09.02. | Mexican discount grocery chain BBB Foods prices US IPO at $17.50, the high end of the revised range | ||
09.02. | Cormorant's SPAC Helix Acquisition II prices further upsized $160 million IPO | ||
09.02. | Gene editing biotech Metagenomi prices IPO at $15, the low end of the range | ||
09.02. | Hemochromatosis drug developer Telomir Pharmaceuticals prices IPO at $7 |